A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

NCT06039826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight

Interventions

DRUG: LY3437943
DRUG: Ethinyl Estradiol
DRUG: Drospirenone

Sponsor

Eli Lilly and Company